Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Preventive HIV Therapy May Limit Later Response - MedPage Today
MD News (press release)Preventive HIV Therapy May Limit Later ResponseMedPage TodayIn concurrent parallel trials, they were treated with a combination of tenofovir and emtricitabine (Truvada) plus either nevirapine or lopinavir-ritonavir. ...Nevirapine May Not Always Be Best Choice for Peripartum Antiretroviral TreatmentMedscapeStudies Tout Alternative HIV Regimens for Women, BabiesBusinessWeekWHO Updates HIV Treatment Guidelines for Women and InfantsAIDSmeds.com HIV/AIDS Treatment NewsPediatric SuperSite�-MD News (press release)all 28 news articles��
Viread(R) for Hepatitis B Maintains Antiviral Suppression with No Development ... - MarketWatch (press release)
Viread(R) for Hepatitis B Maintains Antiviral Suppression with No Development ...MarketWatch (press release)Use atazanavir with Viread only with additional ritonavir; monitor for evidence of tenofovir toxicity. Coadministration of Viread with lopinavir/ritonavir ...and more��
Abbott earnings hit by charges but pharma sales soar - Pharma Times
Abbott earnings hit by charges but pharma sales soarPharma Times... therapy Lupron (leuprolide) fell 3.3% to $189 million, while revenues from the HIV drug Kaletra (lopinavir/ritonavir) plunged 7.2% to $328 million. ...and more��
Studies Indicate Kaletra-Based Therapy Is Better Than Viramune-Based Therapy ... - The AIDS Beacon
Studies Indicate Kaletra-Based Therapy Is Better Than Viramune-Based Therapy ...The AIDS BeaconThe WHO now recommends that Kaletra (ritonavir/lopinavir)-based treatment be used for women and children with previous exposure to single-dose Viramune ...
Last updated on: Jan 24, 2007
Brand Name: | Arava |
Active Ingredient: | lopinavir/ritonavir |
Strength(s): | 133.3/33.3mg Capsules, 80/20mg/ml Oral Solution and 200/50mg Tablets |
Dosage Form(s): | Capsules, Oral Solution and Tablets |
Company Name: | Abbott Pharmaceuticals |
Availability: | Prescription only |
*Date Approved by FDA: | September 15, 2000 |
*Approval by FDA does not mean that the drug is available for consumers at this time.
This information is provided by the U.S. Food & Drug Administration.
For more information about this drug, click here. |
What is Kaletra used for?
Who should not take Kaletra?
Together with your doctor, you need to decide whether Kaletra is right for you.
Special Warnings with Kaletra:
What should I tell my doctor or healthcare provider?
Tell your doctor or healthcare provider if you:
What are some possible side effects of Kaletra? (This is NOT a complete list of side effects reported with Kaletra. Your healthcare provider can discuss with you a more complete list of side effects.)
The most commonly reported side effects that are thought to be drug related are:
Accupril
Actonel
Actos
Allegra
Altace
Atenolol
Avandia
Celebrex
Celexa
Cialis
Coreg
Cozaar
Crestor
Diovan
Effexor
Evista
Flomax
Fluoxetine
Fosamax
Glucophage
Latisse
Levitra
Levoxyl
Lexapro
Lipitor
Lisinopril
Metformin
Neurontin
Nexium
Norvasc
Paxil
Plavix
Pravachol
Premarin
Prevacid
Prilosec
Propecia
Protonix
Prozac
Seroquel
Simvastatin
Singulair
Toprol-XL
Viagra
Zetia
Zithromax
Zocor
Zoloft
Zyprexa
Zyrtec